The US Centers for Disease Control and Prevention (CDC) is advising clinicians to begin antiviral treatment as soon as possible for individuals with suspected or confirmed H7N9 influenza infection, according to a guidance document issued by the agency in April (http://tinyurl.com/d4gzab7).
Since China first alerted global public health officials of an outbreak of H7N9 influenza on March 31, a total of 126 laboratory-confirmed human cases have occurred, according to the World Health Organization (WHO) at press time (http://tinyurl.com/crybbkd). Most of the identified patients have developed severe pneumonia and 24 had died. However, the WHO said the full range of illness may not be known (http://tinyurl.com/bvgk8p8). The source of infections has not yet been confirmed, although Chinese authorities had found infected poultry at markets. So far, the WHO said there is no evidence of human-to-human transmission.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
The Rational Clinical Examination
Make the Diagnosis: Influenza
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.